Maywufa Company Ltd.

NT$20.70As of Sun 8 Nov 2026, 12:00 UTC
TWSE:1731Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR 9.84%
Div yield 5.89%
ROE 9.53%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.11
PE TTM 13.71
TSR TTM 0.57%
Mkt cap NT$2.751B
ROIC 7.94%
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$23
12.37%
(71.46%)
Hold 4|12|9|1|3
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.30
0.33
0.32
0.32
20.73%
33.76%
18.68%
12.23%
RevenueNT$M
129.3
132.2
128.9
135.9
0.58%
2.39%
1.71%
2.81%
Peers (US$83.10M)
Cap (US$)
PE
78.24M
12.80x
Capital
TTM
5Y
10Y
Leveragex
0.750
0.103
0.105
EBIT/Intx
1.015
0.172
0.172
Own earn%
(22.08)
(41.63)
(40.81)
Sh yield%
28.73
28.61
24.87
Owners
Insiders/Inst%
6.95
28.90
Short interest%
2.84
SBC / revenue%
4.07
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
15–23
$1 testx
0.2
Incr. ROIC%
1